O. Balogh

发表

Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of rheumatoid arthritis

M. Péntek, P. Baji, V. Brodszky, 2014 .

Surgically treated intraoperative coronary embolism.

A. Jánosi, D. Szilard, O. Balogh, 2006, The Thoracic and cardiovascular surgeon.

[Quality of life and burden of disease in peripheral arterial disease: a study among Hungarian patients].

M. Péntek, V. Brodszky, L. Gulácsi, 2013, Orvosi hetilap.

Moderate to severe psoriasis patients' subjective future expectations regarding health‐related quality of life and longevity

É. Remenyik, M. Péntek, V. Brodszky, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

The German approach to cost-effectiveness analysis in health care

O. Balogh, N. V. Hevér, 2013 .

Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey.

V. Brodszky, L. Gulácsi, O. Balogh, 2015, Archives of Iranian medicine.

[Disease burden of psoriasis associated with psoriatic arthritis in Hungary].

É. Remenyik, M. Péntek, V. Brodszky, 2014, Orvosi hetilap.

Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres

É. Remenyik, P. Baji, V. Brodszky, 2014, The European Journal of Health Economics.

Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary

É. Remenyik, M. Péntek, V. Brodszky, 2014, The European Journal of Health Economics.

Exploring the relationship between EQ-5 D , DLQI and PASI , 3 and mapping EQ-5 D utilities : a cross-sectional study in psoriasis 4 from Hungary 5

É. Remenyik, M. Péntek, V. Brodszky, 2014 .

Investigation of Circulating MicroRNA Levels in Antibody-Mediated Rejection After Kidney Transplantation.

O. Balogh, E. Szabó, Z. Fejes, 2022, Transplantation proceedings.

Krónikus betegségek biológiai terápiájának alkalmazásával kapcsolatos gazdasági megfontolások = Economic consideration of the implementation of biotechnological therapies in chronic diseases

O. Balogh, 2014 .

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis

M. Péntek, P. Baji, V. Brodszky, 2014, The European Journal of Health Economics.

Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries

M. Péntek, P. Baji, V. Brodszky, 2014, The European Journal of Health Economics.

[Effectiveness of prostanoids in patients with critical leg ischemia].

M. Péntek, P. Baji, V. Brodszky, 2011, Orvosi hetilap.

Image Quality of Prospectively ECG-Triggered Coronary CT Angiography in Heart Transplant Recipients.

B. Merkely, P. Maurovich-Horvat, B. Szilveszter, 2017, AJR. American journal of roentgenology.

PUK7 Cost of Illness of Overactive Bladder Syndrome in Hungary

M. Péntek, P. Baji, V. Brodszky, 2012 .

irudin doses were low in the group without (0.81 ± 0.13 mg/kg b. w.) as well as in the group with renal insufficiency

A. Jánosi, D. Szilard, O. Balogh, 2022 .

Moderate to severe psoriasis patients' subjective future expectations regarding health‐related quality of life and longevity

M. Péntek, V. Brodszky, L. Gulácsi, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Image Quality of Prospectively ECG-Triggered Coronary CT Angiography in Heart Transplant Recipients.

B. Merkely, P. Maurovich-Horvat, B. Szilveszter, 2017, AJR. American journal of roentgenology.